Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
QuintilesIMS
US Department of Justice
Fish and Richardson
Queensland Health
Deloitte
Chinese Patent Office
Medtronic
Daiichi Sankyo

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019853

« Back to Dashboard

NDA 019853 describes CUPRIMINE, which is a drug marketed by Aton and is included in one NDA. It is available from one supplier. Additional details are available on the CUPRIMINE profile page.

The generic ingredient in CUPRIMINE is penicillamine. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the penicillamine profile page.
Summary for 019853
Tradename:CUPRIMINE
Applicant:Aton
Ingredient:penicillamine
Patents:0
Therapeutic Class:Antidotes, Deterrents, and Toxicologic Agents
Genitourinary Agents
Immunological Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 019853
Medical Subject Heading (MeSH) Categories for 019853
Suppliers and Packaging for NDA: 019853
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CUPRIMINE penicillamine CAPSULE;ORAL 019853 NDA Aton Pharma, Inc. 25010-705 N 25010-705-15

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength125MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Medtronic
Baxter
UBS
Colorcon
Fuji
Mallinckrodt
Daiichi Sankyo
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.